 Genevieve Sparagna
Concepts (333)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiolipins | 33 | 2023 | 71 | 4.240 |
Why?
| | Myocardium | 20 | 2021 | 922 | 1.980 |
Why?
| | Mitochondria, Heart | 18 | 2022 | 73 | 1.800 |
Why?
| | Mitochondria | 18 | 2023 | 750 | 1.030 |
Why?
| | Acyltransferases | 11 | 2022 | 46 | 0.890 |
Why?
| | Heart Failure | 12 | 2016 | 1962 | 0.860 |
Why?
| | Barth Syndrome | 4 | 2022 | 8 | 0.800 |
Why?
| | Phospholipids | 10 | 2023 | 199 | 0.790 |
Why?
| | Linoleic Acid | 6 | 2023 | 38 | 0.770 |
Why?
| | Myocytes, Cardiac | 7 | 2022 | 448 | 0.590 |
Why?
| | Fatty Acids | 9 | 2023 | 385 | 0.570 |
Why?
| | Rats | 25 | 2022 | 4973 | 0.540 |
Why?
| | Electron Transport Complex III | 7 | 2017 | 11 | 0.520 |
Why?
| | Mitochondria, Liver | 6 | 2017 | 66 | 0.520 |
Why?
| | Diet, High-Fat | 4 | 2021 | 225 | 0.500 |
Why?
| | Palmitic Acid | 3 | 2004 | 36 | 0.470 |
Why?
| | Animal Feed | 2 | 2013 | 49 | 0.440 |
Why?
| | Rats, Inbred SHR | 9 | 2013 | 41 | 0.430 |
Why?
| | Animals | 46 | 2023 | 31867 | 0.410 |
Why?
| | Apoptosis | 7 | 2009 | 2366 | 0.410 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2009 | 103 | 0.390 |
Why?
| | Berberine | 2 | 2021 | 6 | 0.390 |
Why?
| | Electron Transport Complex IV | 4 | 2012 | 53 | 0.360 |
Why?
| | Calcium | 9 | 2010 | 1104 | 0.360 |
Why?
| | Phospholipases A2, Calcium-Independent | 1 | 2009 | 4 | 0.340 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2021 | 122 | 0.330 |
Why?
| | Saccharomyces cerevisiae | 3 | 2023 | 477 | 0.320 |
Why?
| | Myocardial Reperfusion Injury | 3 | 2013 | 91 | 0.320 |
Why?
| | Fundulidae | 2 | 2018 | 2 | 0.320 |
Why?
| | Diet | 3 | 2023 | 1076 | 0.310 |
Why?
| | Oxidation-Reduction | 11 | 2021 | 926 | 0.300 |
Why?
| | Diabetes, Gestational | 2 | 2021 | 281 | 0.280 |
Why?
| | Dietary Fats | 5 | 2023 | 290 | 0.280 |
Why?
| | Enzyme Inhibitors | 5 | 2013 | 752 | 0.280 |
Why?
| | Acclimatization | 2 | 2018 | 150 | 0.280 |
Why?
| | Electron Transport Complex I | 3 | 2021 | 33 | 0.270 |
Why?
| | Mitochondrial Membrane Transport Proteins | 4 | 2010 | 29 | 0.260 |
Why?
| | Rats, Sprague-Dawley | 9 | 2009 | 2212 | 0.260 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2012 | 162 | 0.260 |
Why?
| | Liver | 4 | 2023 | 1681 | 0.260 |
Why?
| | Disease | 1 | 2006 | 86 | 0.260 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2023 | 333 | 0.250 |
Why?
| | Heart | 4 | 2017 | 610 | 0.250 |
Why?
| | Docosahexaenoic Acids | 3 | 2017 | 69 | 0.250 |
Why?
| | Transcription Factors | 6 | 2022 | 1531 | 0.250 |
Why?
| | Ischemia | 3 | 2018 | 363 | 0.250 |
Why?
| | Mitochondrial Membranes | 2 | 2018 | 32 | 0.230 |
Why?
| | Body Weight | 6 | 2021 | 873 | 0.210 |
Why?
| | Cardiomyopathy, Dilated | 3 | 2014 | 351 | 0.210 |
Why?
| | Reactive Oxygen Species | 3 | 2020 | 536 | 0.200 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2021 | 85 | 0.190 |
Why?
| | Mitochondrial Diseases | 1 | 2022 | 77 | 0.190 |
Why?
| | Lipid Metabolism | 3 | 2020 | 449 | 0.190 |
Why?
| | Heart Diseases | 2 | 2021 | 330 | 0.190 |
Why?
| | Palmitates | 1 | 2000 | 16 | 0.180 |
Why?
| | Coenzyme A | 1 | 2020 | 6 | 0.180 |
Why?
| | B-Lymphocytes | 2 | 2022 | 772 | 0.180 |
Why?
| | Maternal-Fetal Exchange | 1 | 2021 | 151 | 0.180 |
Why?
| | Vascular Remodeling | 1 | 2022 | 153 | 0.180 |
Why?
| | Ethanol | 1 | 2004 | 548 | 0.170 |
Why?
| | Male | 24 | 2023 | 55730 | 0.170 |
Why?
| | Heart Ventricles | 3 | 2020 | 714 | 0.170 |
Why?
| | Physical Conditioning, Animal | 3 | 2008 | 196 | 0.170 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 249 | 0.160 |
Why?
| | Multienzyme Complexes | 2 | 2012 | 64 | 0.160 |
Why?
| | Dietary Supplements | 2 | 2021 | 458 | 0.160 |
Why?
| | Mice | 11 | 2023 | 14927 | 0.160 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 182 | 0.160 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 344 | 0.160 |
Why?
| | Islets of Langerhans | 2 | 2021 | 729 | 0.160 |
Why?
| | Animals, Newborn | 5 | 2022 | 778 | 0.150 |
Why?
| | Cardiomyopathies | 1 | 2021 | 300 | 0.150 |
Why?
| | Thermotolerance | 1 | 2018 | 6 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2020 | 316 | 0.150 |
Why?
| | Optic Atrophy, Autosomal Dominant | 1 | 2017 | 1 | 0.150 |
Why?
| | Dynamins | 1 | 2017 | 29 | 0.150 |
Why?
| | Mitochondrial Dynamics | 1 | 2017 | 23 | 0.150 |
Why?
| | Cells, Cultured | 7 | 2021 | 3896 | 0.150 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 93 | 0.150 |
Why?
| | Intermittent Claudication | 1 | 2018 | 108 | 0.150 |
Why?
| | Eicosapentaenoic Acid | 3 | 2017 | 28 | 0.150 |
Why?
| | Phenotype | 3 | 2022 | 2815 | 0.140 |
Why?
| | Hypertension | 4 | 2008 | 1058 | 0.140 |
Why?
| | Blood Pressure | 7 | 2013 | 1539 | 0.140 |
Why?
| | Phosphatidylglycerols | 2 | 2023 | 20 | 0.140 |
Why?
| | A Kinase Anchor Proteins | 1 | 2017 | 65 | 0.140 |
Why?
| | Mitochondrial Proteins | 2 | 2016 | 220 | 0.140 |
Why?
| | Female | 17 | 2022 | 59611 | 0.140 |
Why?
| | Disease Models, Animal | 7 | 2022 | 3545 | 0.140 |
Why?
| | Cytochrome c Group | 3 | 2001 | 36 | 0.140 |
Why?
| | Signal Transduction | 5 | 2021 | 4525 | 0.130 |
Why?
| | Sirtuins | 1 | 2016 | 32 | 0.130 |
Why?
| | Mitochondrial Trifunctional Protein, alpha Subunit | 1 | 2015 | 1 | 0.130 |
Why?
| | Temperature | 1 | 2018 | 578 | 0.130 |
Why?
| | Huntington Disease | 1 | 2016 | 38 | 0.130 |
Why?
| | Gene Expression | 4 | 2021 | 1423 | 0.130 |
Why?
| | Electron Transport | 4 | 2021 | 109 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 399 | 0.120 |
Why?
| | Caspases | 4 | 2013 | 245 | 0.120 |
Why?
| | Lymphocytes | 1 | 2016 | 334 | 0.120 |
Why?
| | Fatty Liver | 1 | 2016 | 217 | 0.110 |
Why?
| | Linoleoyl-CoA Desaturase | 1 | 2013 | 3 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2021 | 1955 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2021 | 1700 | 0.110 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4718 | 0.110 |
Why?
| | Spectrometry, Fluorescence | 1 | 1994 | 157 | 0.110 |
Why?
| | Oleic Acid | 3 | 2022 | 30 | 0.110 |
Why?
| | Aging | 3 | 2008 | 1624 | 0.110 |
Why?
| | Peripheral Arterial Disease | 1 | 2018 | 380 | 0.100 |
Why?
| | Echocardiography | 5 | 2020 | 557 | 0.100 |
Why?
| | Safflower Oil | 1 | 2012 | 7 | 0.100 |
Why?
| | Lysophospholipids | 2 | 2012 | 65 | 0.100 |
Why?
| | Citrate (si)-Synthase | 3 | 2007 | 46 | 0.100 |
Why?
| | Time Factors | 4 | 2009 | 6141 | 0.100 |
Why?
| | Electron Transport Complex II | 1 | 2011 | 23 | 0.100 |
Why?
| | Cryoelectron Microscopy | 1 | 2012 | 144 | 0.100 |
Why?
| | Myocardial Contraction | 1 | 2013 | 313 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 1729 | 0.090 |
Why?
| | Energy Metabolism | 1 | 2016 | 729 | 0.090 |
Why?
| | Humans | 18 | 2022 | 115039 | 0.090 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2011 | 141 | 0.090 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2001 | 43 | 0.090 |
Why?
| | Nutritional Status | 1 | 2013 | 287 | 0.090 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2011 | 132 | 0.090 |
Why?
| | Ceramides | 2 | 2001 | 94 | 0.090 |
Why?
| | Biological Transport | 5 | 2001 | 372 | 0.090 |
Why?
| | Tissue Survival | 1 | 2009 | 13 | 0.090 |
Why?
| | Fish Oils | 1 | 2009 | 25 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 324 | 0.080 |
Why?
| | Diacylglycerol Cholinephosphotransferase | 1 | 2008 | 1 | 0.080 |
Why?
| | Cytidine Diphosphate Diglycerides | 1 | 2008 | 3 | 0.080 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2008 | 3 | 0.080 |
Why?
| | Phosphatidic Acids | 1 | 2008 | 9 | 0.080 |
Why?
| | Glycochenodeoxycholic Acid | 1 | 2008 | 12 | 0.080 |
Why?
| | alpha-Tocopherol | 1 | 2008 | 24 | 0.080 |
Why?
| | Cardiotonic Agents | 1 | 2009 | 119 | 0.080 |
Why?
| | Mass Spectrometry | 2 | 2017 | 634 | 0.080 |
Why?
| | Rats, Inbred Strains | 1 | 2008 | 376 | 0.080 |
Why?
| | Obesity | 2 | 2021 | 2524 | 0.080 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2009 | 124 | 0.080 |
Why?
| | Adenosine Triphosphate | 3 | 2016 | 431 | 0.080 |
Why?
| | Superoxides | 2 | 2009 | 214 | 0.080 |
Why?
| | Cytosol | 2 | 2000 | 208 | 0.070 |
Why?
| | Rats, Wistar | 3 | 2017 | 369 | 0.070 |
Why?
| | Molecular Structure | 1 | 2009 | 438 | 0.070 |
Why?
| | Calcium-Binding Proteins | 4 | 2008 | 205 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 400 | 0.070 |
Why?
| | Blotting, Western | 4 | 2016 | 1149 | 0.070 |
Why?
| | Rats, Inbred BN | 1 | 2007 | 52 | 0.070 |
Why?
| | Phosphatidylethanolamines | 2 | 2017 | 66 | 0.070 |
Why?
| | Membrane Potentials | 2 | 2000 | 249 | 0.070 |
Why?
| | Heart Function Tests | 2 | 2020 | 59 | 0.070 |
Why?
| | Disease Progression | 1 | 2013 | 2389 | 0.070 |
Why?
| | Phosphatidylcholines | 2 | 2017 | 133 | 0.070 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2006 | 21 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2009 | 377 | 0.070 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 127 | 0.070 |
Why?
| | Cardiac Output, Low | 1 | 2006 | 64 | 0.070 |
Why?
| | Hypothyroidism | 1 | 2006 | 65 | 0.070 |
Why?
| | Pregnancy | 3 | 2022 | 5519 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2020 | 2563 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 337 | 0.060 |
Why?
| | Cyclosporine | 2 | 2009 | 161 | 0.060 |
Why?
| | Chromatography, Gas | 1 | 2005 | 27 | 0.060 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2005 | 125 | 0.060 |
Why?
| | Reference Standards | 1 | 2005 | 159 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2008 | 1019 | 0.060 |
Why?
| | Protein Kinase C-epsilon | 1 | 2004 | 27 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2012 | 791 | 0.060 |
Why?
| | Linoleic Acids | 1 | 2023 | 4 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2021 | 588 | 0.060 |
Why?
| | Cell Respiration | 2 | 2017 | 74 | 0.060 |
Why?
| | Kinetics | 3 | 1998 | 1558 | 0.060 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2007 | 361 | 0.060 |
Why?
| | Caspase 3 | 2 | 2002 | 237 | 0.050 |
Why?
| | Models, Cardiovascular | 1 | 2004 | 179 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2004 | 175 | 0.050 |
Why?
| | Respiration | 1 | 2023 | 182 | 0.050 |
Why?
| | Acyl Coenzyme A | 2 | 2013 | 30 | 0.050 |
Why?
| | Coronary Circulation | 1 | 2003 | 135 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2004 | 275 | 0.050 |
Why?
| | Glucose | 2 | 2021 | 900 | 0.050 |
Why?
| | Hydrogen Peroxide | 2 | 2020 | 287 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2022 | 134 | 0.050 |
Why?
| | Indomethacin | 1 | 2022 | 75 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2022 | 82 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2020 | 2585 | 0.050 |
Why?
| | Cell Line | 2 | 2021 | 2645 | 0.050 |
Why?
| | Interleukin-4 | 1 | 2022 | 209 | 0.050 |
Why?
| | Doxycycline | 1 | 2021 | 55 | 0.050 |
Why?
| | Child, Preschool | 3 | 2021 | 9093 | 0.050 |
Why?
| | Phenylephrine | 1 | 2021 | 74 | 0.050 |
Why?
| | Mitochondrial Swelling | 1 | 2000 | 1 | 0.050 |
Why?
| | Culture Media | 1 | 2021 | 155 | 0.050 |
Why?
| | Myofibrils | 1 | 2021 | 46 | 0.050 |
Why?
| | Sarcomeres | 1 | 2021 | 90 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 609 | 0.050 |
Why?
| | Ruthenium Red | 2 | 2001 | 8 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2002 | 185 | 0.040 |
Why?
| | Caspase Inhibitors | 1 | 2000 | 78 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 297 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2000 | 87 | 0.040 |
Why?
| | Oxidative Phosphorylation | 2 | 2017 | 156 | 0.040 |
Why?
| | Spermine | 2 | 2001 | 27 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 299 | 0.040 |
Why?
| | Ion Channels | 1 | 2000 | 124 | 0.040 |
Why?
| | Respiratory Function Tests | 1 | 2022 | 523 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 1857 | 0.040 |
Why?
| | Swine | 2 | 2013 | 704 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 496 | 0.040 |
Why?
| | Pancreas | 1 | 2021 | 280 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 817 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 454 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2000 | 300 | 0.040 |
Why?
| | Aged | 3 | 2018 | 19119 | 0.040 |
Why?
| | Ankle Brachial Index | 1 | 2018 | 30 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 387 | 0.040 |
Why?
| | Lipids | 2 | 2012 | 586 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 183 | 0.040 |
Why?
| | Organ Size | 2 | 2009 | 444 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 213 | 0.040 |
Why?
| | Cellular Microenvironment | 1 | 2018 | 78 | 0.040 |
Why?
| | Isolated Heart Preparation | 1 | 2017 | 2 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 227 | 0.040 |
Why?
| | Insulin | 2 | 2021 | 2082 | 0.040 |
Why?
| | Atrial Natriuretic Factor | 2 | 2009 | 57 | 0.040 |
Why?
| | Protein Binding | 2 | 2012 | 1898 | 0.040 |
Why?
| | Middle Aged | 3 | 2018 | 26827 | 0.030 |
Why?
| | Enzymes | 1 | 2017 | 62 | 0.030 |
Why?
| | Adult | 3 | 2022 | 30655 | 0.030 |
Why?
| | Myocardial Infarction | 1 | 2003 | 930 | 0.030 |
Why?
| | Adiposity | 1 | 2021 | 466 | 0.030 |
Why?
| | Myosin Heavy Chains | 2 | 2009 | 177 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 57 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 799 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1634 | 0.030 |
Why?
| | Child | 3 | 2021 | 18407 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 2 | 2008 | 814 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 958 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2021 | 450 | 0.030 |
Why?
| | Infant | 2 | 2021 | 7945 | 0.030 |
Why?
| | Hepatocytes | 1 | 2016 | 196 | 0.030 |
Why?
| | Herpesvirus 4, Human | 1 | 2016 | 125 | 0.030 |
Why?
| | Calcium Channels | 3 | 2001 | 146 | 0.030 |
Why?
| | Atherosclerosis | 1 | 2018 | 342 | 0.030 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2016 | 72 | 0.030 |
Why?
| | Glycolysis | 1 | 2016 | 227 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3015 | 0.030 |
Why?
| | Age Factors | 2 | 2014 | 2894 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1523 | 0.030 |
Why?
| | Egtazic Acid | 1 | 1994 | 44 | 0.030 |
Why?
| | DNA | 1 | 2001 | 1352 | 0.030 |
Why?
| | Automation | 1 | 1994 | 73 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2020 | 1085 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1636 | 0.030 |
Why?
| | Ventricular Function, Left | 2 | 2009 | 469 | 0.030 |
Why?
| | Weight Gain | 1 | 2016 | 451 | 0.030 |
Why?
| | Cytochrome Reductases | 1 | 2012 | 3 | 0.030 |
Why?
| | Mitochondrial Trifunctional Protein | 1 | 2012 | 1 | 0.030 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2012 | 2 | 0.030 |
Why?
| | Phospholipases | 1 | 2012 | 13 | 0.030 |
Why?
| | Proteolipids | 1 | 2012 | 28 | 0.030 |
Why?
| | Ubiquinone | 1 | 2012 | 21 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2013 | 71 | 0.030 |
Why?
| | Thyroxine | 1 | 2012 | 58 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2014 | 5040 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 2012 | 410 | 0.030 |
Why?
| | Protein Structure, Quaternary | 1 | 2012 | 115 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2012 | 325 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2012 | 355 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2011 | 78 | 0.020 |
Why?
| | Antioxidants | 2 | 2008 | 530 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3350 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 276 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 368 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2012 | 503 | 0.020 |
Why?
| | Superoxide Dismutase | 2 | 2003 | 305 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 548 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 437 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2012 | 405 | 0.020 |
Why?
| | Models, Chemical | 1 | 2012 | 250 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 17862 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 3419 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2012 | 616 | 0.020 |
Why?
| | Thromboxane B2 | 1 | 2009 | 27 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 798 | 0.020 |
Why?
| | Constriction | 1 | 2009 | 45 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1477 | 0.020 |
Why?
| | Aorta, Abdominal | 1 | 2009 | 39 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 928 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2009 | 117 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 1017 | 0.020 |
Why?
| | Thromboxanes | 1 | 2008 | 16 | 0.020 |
Why?
| | Rats, Mutant Strains | 1 | 2008 | 25 | 0.020 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2011 | 417 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 1990 | 0.020 |
Why?
| | Cytochromes c | 1 | 2008 | 62 | 0.020 |
Why?
| | Phosphorylation | 1 | 2013 | 1572 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4411 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2014 | 669 | 0.020 |
Why?
| | Diet, Fat-Restricted | 1 | 2008 | 73 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2796 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6357 | 0.020 |
Why?
| | Dietary Carbohydrates | 1 | 2008 | 136 | 0.020 |
Why?
| | Cell Death | 1 | 2008 | 324 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 1843 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1028 | 0.020 |
Why?
| | Isomerism | 1 | 2005 | 43 | 0.020 |
Why?
| | RNA | 1 | 2011 | 810 | 0.020 |
Why?
| | Cell Size | 1 | 2005 | 81 | 0.020 |
Why?
| | Proteinuria | 1 | 2005 | 77 | 0.020 |
Why?
| | Exercise Test | 1 | 2007 | 545 | 0.010 |
Why?
| | Cell Separation | 1 | 2005 | 291 | 0.010 |
Why?
| | Leptin | 1 | 2005 | 211 | 0.010 |
Why?
| | Blood Glucose | 1 | 2013 | 1821 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2329 | 0.010 |
Why?
| | Ditiocarb | 1 | 2002 | 3 | 0.010 |
Why?
| | Survival Analysis | 1 | 2005 | 1211 | 0.010 |
Why?
| | Fluoresceins | 1 | 2002 | 46 | 0.010 |
Why?
| | Tibia | 1 | 2003 | 168 | 0.010 |
Why?
| | Chelating Agents | 1 | 2002 | 65 | 0.010 |
Why?
| | Calcium Radioisotopes | 1 | 2001 | 3 | 0.010 |
Why?
| | Adenylate Kinase | 1 | 2001 | 27 | 0.010 |
Why?
| | Adenosine Monophosphate | 1 | 2001 | 49 | 0.010 |
Why?
| | Adenosine Diphosphate | 1 | 2001 | 81 | 0.010 |
Why?
| | Chickens | 1 | 2001 | 177 | 0.010 |
Why?
| | Sodium | 1 | 2000 | 183 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2003 | 698 | 0.010 |
Why?
| | Electric Conductivity | 1 | 1998 | 88 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 637 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2002 | 827 | 0.010 |
Why?
| | Proteins | 1 | 2002 | 915 | 0.010 |
Why?
| | Brain | 1 | 1998 | 2379 | 0.000 |
Why?
|
|
Sparagna's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|